loader image
Tuesday, January 13, 2026
54.4 F
McAllen
- Advertisement -

An Overactive Sweet Tooth May Spell Trouble for Our Cellular Powerplants

Translate to Spanish or other 102 languages!

Image for Illustration purposes

Mega Doctor News

- Advertisement -

By Van Andel Institute

Newswise — GRAND RAPIDS, MI — The average American eats roughly 22 teaspoons of added sugar a day — more than three times the recommended amount for women and more than double the recommended amount for men.

Although this overconsumption is known to contribute to Type 2 diabetes and other disorders, the exact ways in which eating too much sugar sets the stage for metabolic diseases on a cellular level has been less clear.

- Advertisement -

Now, a team led by Van Andel Institute scientists has found that surplus sugar may cause our cellular powerplants — called mitochondria— to become less efficient, reducing their energy output.

The findings, published today in Cell Reports, highlight the cellular implications of excessive sugar consumption and provide an important new model to study the initial metabolic events that may contribute to diabetes development.

Image Courtesy Van Andel Institute
Ning Wu, Ph.D.

“The body needs sugar, or glucose, to survive, but, as the saying goes: ‘All good things in moderation,’” said Ning Wu, Ph.D., an assistant professor at Van Andel Institute and corresponding author of the study. “We found that too much glucose in cells, which is directly linked to the amount of sugar consumed in one’s diet, affects lipid composition throughout the body, which in turn affects the integrity of mitochondria. The overall effect is a loss of optimal function.”

Using their new model, Wu and her colleagues demonstrated that excess glucose reduces the concentration of polyunsaturated fatty acids (PUFAs) in the mitochondrial membrane and makes mitochondria less efficient. PUFAs are vital players in supporting mitochondrial function and mediating a host of other biological processes such as inflammation, blood pressure and cellular communication.

- Advertisement -

Instead, excess glucose is synthesized into a different form of fatty acid that isn’t as efficient or as flexible as PUFAs. This upends the lipid composition of the membrane and puts stress on the mitochondria, damaging them and impacting their performance.

Wu and her colleagues were able to reverse this detrimental effect by feeding their mouse models a low-sugar ketogenic diet, which suggests that reducing glucose and restoring normal membrane lipid composition supports healthy mitochondrial integrity and function. They also found that consuming excess carbohydrates reduces the beneficial effect of PUFA supplements.

“Although we may not always notice the difference in mitochondrial performance right away, our bodies do,” Wu explained. “If the lipid balance is thrown off for long enough, we may begin to feel subtle changes, such as tiring more quickly. While our study does not offer medical recommendations, it does illuminate the early stages of metabolic disease and provides insights that may shape future prevention and therapeutic efforts.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Named Among America’s Best for Minimally Invasive Surgery

Minimally invasive surgery is significantly on the rise in the United States, driven by the demand for shorter recovery, less pain and improved patient outcomes following a surgical procedure.

TxDOT Leads Statewide Effort to Expose and End Human Trafficking

Being a good Texan on the road isn’t just about driving kind, courteous and safe. It’s about looking out for each other, and that includes watching for the signs of human trafficking.

AI Accurately Predicts Prostate Cancer Recurrence

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care necessary in the follow-up journey, Mayo Clinic’s Department of Radiation Oncology developed the PSA Control Tower.

Immunotherapy Plus Surgery Benefits Lung Cancer Patients

Perioperative nivolumab plus neoadjuvant chemotherapy improved outcomes for patients regardless of whether their cancer had spread to their lymph nodes.
- Advertisement -
×